Vikram Narayan

Associate Director at Frontier Medicines

Vikram Narayan is an Associate Director at Frontier Medicines, based in the San Francisco Bay Area.1 Here are some key details about his background and current role:

Education and Training

Vikram Narayan has an extensive educational background in biochemistry and molecular biology:

He received his PhD training in Edinburgh, where he studied E3 ligase biology and identified CHIP as an E3 ligase regulating the tumor suppressor protein IRF-1.1
He later conducted postdoctoral research on aging, funded by a Wellcome Trust grant, at the University of Dundee and the University of California, San Francisco.1

Career Path

Narayan's career has spanned both academia and industry:

After his postdoctoral work, he transitioned to the biotech industry, joining Calico Life Sciences, an Alphabet-funded venture focused on combating aging and age-related diseases.1
He spent about 6 years at Calico, applying his expertise in biochemistry, cell biology, proteomics, and molecular biology to study aging using the naked mole-rat as a model organism.1
Currently, he serves as an Associate Director of Disease Biology at Frontier Medicines.1

Current Role at Frontier Medicines

At Frontier Medicines, Vikram Narayan:

Leads novel E3 ligase degrader programs as part of a partnership with AbbVie.1
Applies his graduate training and expertise in E3 ligase biology to drug development efforts.1
Works hands-on at the bench with his team to develop tailored cellular assays for novel degraders.1

Professional Interests

Narayan is passionate about:

Translating basic research into effective therapeutics for patients.1
Exploring the interface between basic research, drug development, and patient care.1
Bringing better drugs to patients faster.1

Vikram Narayan's LinkedIn profile (username: vikramn) provides more details about his professional background and current work at Frontier Medicines.1